Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-04-17-13-30-18-435-69e235ea1a76544fc58084ea.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-04-14-13-28-10-783-69de40ea39776dfb165aec1c.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-04-13-14-19-41-498-69dcfb7d6d7258fe4b8be45e.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-04-17-13-14-02-059-69e2321a0c516f447315e0ad.jpg)